Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Cross Country Healthcare
CCRN
Market cap
$336M
Overview
Fund Trends
Analyst Outlook
Journalist POV
10.26
USD
-0.41
3.84%
At close
Updated
Nov 28, 4:00 PM EST
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
-3.84%
5 days
-5%
1 month
-17.85%
3 months
-23.26%
6 months
-23.6%
Year to date
-43.53%
1 year
-4.65%
5 years
17.93%
10 years
-43.78%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
40%
Negative
Positive
Neutral
Negative
Negative
Zacks Investment Research
18 days ago
Cross Country Healthcare (CCRN) Lags Q3 Earnings and Revenue Estimates
Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.12 per share a year ago.
Neutral
Business Wire
18 days ago
Cross Country Healthcare Announces Third Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2025. Selected Financial Information: Variance Variance Q3 2025 vs Q3 2025 vs Dollars are in thousands, except per share amounts Q3 2025 Q3 2024 Q2 2025 Revenue $ 250,052 (21 )% (9 )% Gross profit margin* 20.4 % — bps — bps Net loss attributable to common stockholders $ (4,774 ) (287 )% 28 % Diluted EPS.
Neutral
Business Wire
1 month ago
Cross Country Marketing Team Wins Global OnCon Icon Award; Named No. 1 in the Nation
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country announced today that its marketing team has been named the No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards.
Positive
Zacks Investment Research
1 month ago
KELYA or CCRN: Which Is the Better Value Stock Right Now?
Investors interested in Staffing Firms stocks are likely familiar with Kelly Services (KELYA) and Cross Country Healthcare (CCRN). But which of these two companies is the best option for those looking for undervalued stocks?
Negative
Zacks Investment Research
2 months ago
New Strong Sell Stocks for October 1st
AGL, PLAY and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025.
Negative
Zacks Investment Research
3 months ago
New Strong Sell Stocks for August 20th
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
Neutral
The Motley Fool
3 months ago
CCRN Earnings Drop 19%
Cross Country Healthcare (CCRN 2.02%), a major provider of healthcare staffing solutions, reported its second quarter results on August 6, 2025. The company reported a substantial miss on both GAAP revenue and non-GAAP EPS.
Negative
Zacks Investment Research
3 months ago
Cross Country Healthcare (CCRN) Reports Q2 Loss, Misses Revenue Estimates
Cross Country Healthcare (CCRN) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.1 per share a year ago.
Neutral
Business Wire
3 months ago
Cross Country Healthcare Announces Second Quarter 2025 Financial Results
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its second quarter ended June 30, 2025. Selected Financial Information: Variance Variance Q2 2025 vs Q2 2025 vs Dollars are in thousands, except per share amounts Q2 2025 Q2 2024 Q1 2025 Revenue $ 274,072 (19 )% (7 )% Gross profit margin* 20.4 % (40 )bps 40 bps Net loss attributable to common stockholders $ (6,659 ) (59 )% (1,259 )% Diluted.
Negative
Zacks Investment Research
4 months ago
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close